[Clinical observations on treatment with flufenazin dihydrochloride (Lyorodin--Jenapharm)].
According to the psycho-pharmacological characteristics, indications, counterindications and side-effects of fluophenazine dihydrochloride, the authors present the results of a simple-blind study of Lyorodin--Jenapharm in a series of 30 in-patients of both sexes, aged between 30 and 65 years. Nosologically, there were cases of schizophrenia and post-process states, delirious hallucinatory syndromes of involution and asthenodithymic syndromes. The drug under the form of pills of 1 and 4 mg was given at average doses of 2-4 mg up to 6-10 mg for 28 days under clinical surveillance and laboratory tests. The estimation of the clinical results revealed the improvement of the symptoms in all investigated cases, a favourable evolution, low incidence and intensity of its side-effects, good tolerance and clinical efficacy comparable to that of Lyogen.
Chiriţă
V
V
Pirozynski
T
T
D000328:Adult; D000368:Aged; D003693:Delirium / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects / Q000627:therapeutic use*; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013577:Syndrome; D013607:Tablets
D013607:Tablets; D005476:Fluphenazine
Observaţii clinice asupra tratamentului cu diclorhidrat de flufenazină (Lyorodin--Jenapharm).